Global Biochips Market 2018 Size, Share, Technologies, Key Players (DANAHER CORP, ILLUMINA, ROCHE HOLDING & THERMO FISHER SCIENTIFIC), Global Trends Analysis, Growth Factors & 2023 Opportunities

Browse 36 data tables spread through 98 Pages and in-depth TOC on “Global Biochips Market 2018 by Type, by End-Users; by Applications , by Regions – Global Forecast to 2023.

The Biochips Market reached a value of nearly REDACTED in 2018 and is expected to grow at a compound annual growth rate (CAGR) of REDACTED to nearly REDACTED by 2023. Biochips are mainly usedfor clinical research and testing, drugs screening and DNA analysis.

Get Sample Pages @ http://www.orbisresearch.com/contacts/request-sample/2366836

The Biochips Market growth outlook is positive with significant growth potential for DNA microarray. There is pressure on biochip manufacturers to reduce prices of biochips from medical diagnostic companies and research organizations as biochip prices are limiting the growth of the market. At the same time, increasing use of biochips in pharmaceutical research and development activities, concerns regarding animal testing, rising use of DNA microarrays for cancer diagnosis is contributing to the growth of the Biochips Market.

The market for biochips is relatively concentrated. Major players in the market are Thermo Fisher Scientific, Inc., Roche Holding AG, Illumina, Inc., Danaher Corp. and QIAGEN N.V.

The DNA microarray segment accounted for the largest share of the Biochips Market in 2018 at REDACTED. The highest growth is projected to come from the DNA microarray segment, which is forecast togrow at a CAGR of REDACTED. Major factors for this growth included increasing use of DNA microarray incancer diagnosis and forensic sciences.

North America was the largest region in the Biochips Market, accounting for REDACTED of the global market. It was followed by Western Europe and Asia-Pacific. Going forward, Asia-Pacific is expected to witness the fastest growth in the Biochips Market, estimated at grow at a CAGR of REDACTED, followed by North America which is expected to grow at a CAGR of REDACTED.

The market is challenged by restraints such as unclear regulatory guidelines, skill shortage and ethical and privacy concerns relating to biochips.

Report Scope:

This research report categorizes the Biochips Market by type. Product types include DNA microarray, protein microarray, tissue/cell and glycan microarrays and lab-on-a-chip.

Browse Full Report @ http://www.orbisresearch.com/reports/index/biochip-global-markets-to-2023

Report Includes:

- 36 data tables

- An overview of the global market for biochips

- Analyses of global market trends, with data from 2014 to 2018, and projections of compound annual growth rates (CAGRs) through 2023

- Country-specific data and analysis for USA, China, Spain, Italy, France, India, Japan, Russia, Brazil, UK and Australia

- Insight into the historic and forecast data of the market

- Description of market dynamics, including drivers and restraints

- Discussion of key mergers and acquisitions in the market

- Profiles of major companies in the industry, including Danaher Corp., Illumina, Inc., Qiagen N.V., Roche Holding AG, and Thermo Fisher Scientific

Make an Enquiry @ http://www.orbisresearch.com/contacts/enquiry-before-buying/2366836

Companies Mentioned:

DANAHER CORP.
ILLUMINA, INC.
QIAGEN N.V.
ROCHE HOLDING AG
THERMO FISHER SCIENTIFIC, INC.
 

List of Tables:
Summary Table : Global Biochips Market, Through 2023
Table 1 : Global Biochips Historic Market, Through 2018
Table 2 : Global Biochips Forecast Market, Through 2023
Table 3 : Global Biochips Market, by Segment, 2018
Table 4 : Global Biochips Market, Historic and Forecast Growth Rate, by Segment, 2014-2023
Table 5 : Biochips Market Patents
Table 6 : Global Per Capita Average Biochips Market Expenditure, 2014–2023
Table 7 : Global Biochips Market Value, Market Size as A Percentage of Global GDP, 2014–2023
Table 8 : Global Biochips Market, by Region, 2018
Table 9 : Global Biochips Market, Historic and Forecast Growth Rate, by Region, 2014-2023
Table 10 : Global Biochips Market, by Region, 2018
Table 11 : Asia-Pacific Biochips Market, 2014-2023
Table 12 : Asia-Pacific Biochips Market, by Segment, 2018
Table 13 : Asia-Pacific Biochips Market, Historic and Forecast Growth Rate, by Segment, 2014-2023
Table 14 : Western Europe Biochips Market, 2014-2023
Table 15 : Western Europe Biochips Market, by Segment, 2018
Table 16 : Western Europe Biochips Market, Historic and Forecast Growth Rate, by Segment, 2014-2023
Table 17 : Eastern Europe Biochips Market, 2014-2023
Table 18 : Eastern Europe Biochips Market, by Segment, 2018
Table 19 : Eastern Europe Biochips Market, Historic and Forecast Growth Rate, by Segment, 2014-2023
Table 20 : List of NIH Funding to Universities/Institutes for Organ-on-Chips projects
Table 21 : List of National Center for Advancing Translational Sciences (NCATS) Funding To Universities/Institutes for Tissue Chip Testing Centers
Table 22 : List of NCATS and Center for Advancement of Science Funding to Universities/Institutes for the development of tissue chips technology
Table 23 : North American Biochips Market, 2014-2023
Table 24 : North American Biochips Market, by Segment, 2018
Table 25 : North American Biochips Market, Historic and Forecast Growth Rate, by Segment, 2014-2023
...Continued

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your Market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required Market research study for our clients.

Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email: sales@orbisresearch.com

This release was published on openPR.